Rezulin (troglitazone) for Type II diabetes

March 1997

This month, Parke-Davis will start marketing Rezulin (troglitazone) for Type II diabetes.

This is the first drug in a new class...called "glitazones." These drugs are very useful...they improve insulin sensitivity.

Troglitazone stimulates the uptake of glucose into skeletal muscle cells...and decreases glucose production in the liver.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote